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The protein kinase C activator, phorbol-lZmyristate-lfacetate (PMA), augments he cyclic AMP accumu- 
lation induced by forskolin in pheochromocytoma (PC 12) cells with an EC,, value of 14 nM, while having 
no effect on basal values. At a concentration of 100 nM PMA markedly augmented the magnitude of the 
forskolin response and, in addition, caused aslight increase in the potency of forskolin. PMA also enhanced 
the maximal cyclic AMP accumulation produced by 2-chloroadenosine, and caused a slight increase in 
potency of the adenosine analog. Since PMA mimics the effect of diacylglycerols that form during the turn- 
over of the membrane lipid, phosphatidylinositol, heresults uggest an interrelationship between the sys- 
tems involved in phosphatidylinositol turnover and cyclic AMP generation in PC 12 cells. 
cyclic AMP Phosphatidylin#sito~ Ph~rbo~ ester 
1. INTRODUCTION 
Phorbol esters induce a wide variety of func- 
tional and biochemical changes in many different 
tissues and cells [1,2]. Recently, it has been shown 
that phorbol-12-myristate-13-acetate (PMA) aug- 
ments cyclic AMP (CAMP) accumulation in guinea 
pig cerebral cortical slices [3], lymphoma cells [4], 
pinealocytes [5] and smooth muscle 161. 
Phorbol esters are activators of protein kinase C 
and thereby can mimic the action of 
diacylglycerols, which are a product of receptor- 
mediated phosphatidylinositol turnover PI. 
Agents that initiate phosphatidylinositol me- 
tabolism do augment the accumulation of CAMP 
in brain tissue [3,8] and pinealocytes [5]. An 
augmentation of CAMP production linked to 
phosphatidylinositol turnover, thus, may represent 
a general functional correlate of the enhancement 
of CAMP accumulation by PMA, but this has been 
demonstrated as yet only in brain slices and 
pinealocytes. 
Nerve gr~wth~actor Adertosine 
This study extends the specific interaction of a 
protein kinase C activator with CAMP accumula- 
tion to pheochromoc~oma (PC 12) cells. The 
presence of PMA results in an enhanced respon- 
siveness of the CAMP generating systems to 
2-chloroadenosine and to forskolin in such cells. 
2. MATERIALS AND METHODS 
2.1, CAMP assay 
PC 12 cells, derived from a pheochromocytoma 
tumor of the rat adrenal medulla, were obtained 
from Dr G. Guroff (National Institutes of Health, 
Bethesda, MD). The cells were grown in plastic 
tissue culture flasks in Dulbecco’s modified 
Eagle’s medium (Gibco, Grand Island, NY) with 
6% fetal calf serum, 6% horse serum and a 
penicillin-streptomycin mixture. The cells were 
kept at 37°C in an atmosphere enriched in COZ. 
The cells were washed twice with Hepes buffer 
which contains 25 mM Hepes, 150 mM NaCl, 
5 mM KCI, 1.2 mM MgCl2, 1.2 mM NaH2P04, 
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1.8 mM CaCl2, 10 mM glucose, pH 7.4. After the 
last washing, cells were resuspended in Hepes buf- 
fer supplemented with 0.1% albumin and 0.5 ml 
portions of the cell suspension (about 2-3 x lo6 
cells) were rapidly distributed into plastic vials 
prewarmed to 37°C. The cells were incubated at 
37°C with shaking at 120 cycles/min in a total 
volume of 1 ml Hepes buffer, pH 7.4, containing 
1 pg/ml adenosine deaminase. After 5 min prein- 
cubation the phosphodiesterase inhibitor rolipram 
(ZK 62,711, 30 PM) was added. Other agents were 
added 5 min later. The incubation was continued 
for 10 min. All assays were done in triplicate. The 
incubation was terminated by transferring 800~1 
of the cell suspension into Eppendorf test tubes 
preheated at 95°C. After 3 min incubation at 95°C 
the suspension was centrifuged for 2 min at 12000 
x g. The CAMP concentration in the supernatant 
was determined as described [9]. Materials and 
chemicals were from standard sources as described 
[3,81. 
3. RESULTS 
The phorbol ester PMA had no effect on basal 
CAMP accumulation in PC 12 cells at concentra- 
tions up to 300 nM (fig.1). Forskolin alone at a 
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Fig. 1. Effect of PMA on CAMP accumulation in PC 12 
cells in the absence (M) and presence (+--o) of 
3 /rM forskolin. Values are means of a typical 
experiment done in triplicate. 
concentration of 3 yM increased CAMP accumula- 
tion about S-fold over basal values and PMA 
augmented this forskoiin-stimulated accumulation 
of CAMP in a concentration-dependent manner. 
At the maximally effective concentration of 
100 nM PMA the cyclic AMP levels were up to 
3-fold higher than in the absence of PMA. The 
EC50 of PMA for this effect was 14 nM. Similar 
results were obtained after pretreatment of PC 12 
cells with PMA for 5 min or 30 min before addi- 
tion of forskolin (not shown). 4-0-Methyl-PMA 
(10 PM), a phorbol ester that has no effect on pro- 
tein kinase C [lo], did not affect forskolin-elicited 
accumulation of cyclic AMP (not shown). 
Forskolin induced about a 20-fold increase in ac- 
cumulation of CAMP in PC 12 cells with an EGO 
of 2.1 CM (fig.2). 100 nM PMA induced only a 
slight shift of the concentration-response curve of 
forskolin to the left, but markedly increased the 
magnitude of the maximal stimulation. In the 
presence of PMA, forskolin stimulated accumula- 
tion of CAMP about 30-fold with an E&I of 
1.7 ,uM. 
The phorbol ester also augmented receptor- 
mediated stimulation of CAMP accumulation in 
PC 12 cells. The adenosine analog 2-chloro- 
adenosine increases CAMP levels in PC 12 cells via 
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Fig.2. Effect of forskolin on CAMP accumulation in 
PC 12 cells in the absence (M) and presence 
(O---O} of 100 nM PMA. Values are means of a typical 
experiment done in triphcate. 
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Fig.3. Stimulation of CAMP formation in PC 12 cells by 
2-chloroadenosine in the absence (O-O) and presence 
(M) of 100 nM PMA. Values are means of a typical 
experiment done in triplicate. 
A2 adenoine receptors [11,12]. In the presence of 
100 nM PMA, the EC50 of 2chloroadenosine 
decreased from 3.7 to 1.7 pM, whereas the degree 
of stimulation of CAMP formation increased from 
about 8.5fold to about 11-fold (fig.3). 
A variety of agents, including 6-fluo- 
ronorepinephrine (30 FM), histamine (100 pM), 
serotonin (30 FM), vasoactive intestinal peptide 
(1 PM) and nerve growth factor (50 ng/ml) did not 
augment the accumulation of CAMP elicited by 
10 pM 2-chloroadenosine or 3 PM forskolin during 
10 min incubations with PC 12 cells (not shown). 
4. DISCUSSION 
Phorbol esters, which activate protein kinase C, 
alone have no effect on CAMP accumulation in 
certain cells or tissues, but do augment receptor- 
mediated accumulation of CAMP [3-61. In brain 
tissue and pinealocytes agents that initiate 
phosphatidylinositol turnover also augment 
receptor-mediated accumulation of CAMP [5,8] 
presumably through activation of protein kinase C 
by diacylglycerols [3]. The interrelationship of pro- 
tein kinase C activation and CAMP generating 
systems may prove to be a general phenomenon, 
but as yet has been documented only in brain slices 
[3], lymphoma cells [4], pinealocytes [5] and 
smooth muscle [6]. The generality of the 
phenomenon has now been investigated in PC 12 
cells. 
Enhancement of the CAMP accumulation 
elicited by various agents is not the only effect 
reported for the phorbol esters concerning 
adenylate cyclase systems. In hepatocytes or GH3 
pituitary tumor cells, PMA decreases receptor- 
mediated CAMP accumulation [ 14,151. In epider- 
mal cells, PMA alone enhances CAMP accumula- 
tion [ 161. Phorbol esters in certain systems have 
been reported to mediate a desensitization of 
stimulation of adenylate cyclase by ,&adrenergic 
agonists [17,18]. 
In this study, PC 12 cells have been chosen 
because they have many neuronal characteristics, 
such as production and secretion of the 
neurotransmitters dopamine and norepinephrine, 
electrical excitability and formation of dendrites 
upon the addition of nerve growth factor [13]. 
PMA does augment CAMP in brain tissue, but the 
cell types involved have not been defined. In the 
homogeneous PC 12 system PMA increases 
forskolin- and 2-chloroadenosine-elicited CAMP 
accumulation (fig. l-3). The EC50 of PMA for this 
effect is similar to the ECSO, of about 5 nM, for 
enhancement of fl-adrenergic receptor-mediated 
increases in CAMP levels in pinealocytes [5] and to 
the ECSO, of about 4 nM, for the enhancement of 
Badrenergic receptor-mediated increases of CAMP 
levels in S49 lymphoma cells [4] by 12-0- 
tetradecanoylphorbol-13-acetate. In contrast, the 
EC50 of PMA for augmenting the 2-chloro- 
adenosine response in cerebral cortex synap- 
toneurosomes is about 5 FM [3]. 
Initiation of phosphatidylinositol turnover in 
PC 12 cells presumably would also lead to in- 
creased responses of CAMP-generating systems to 
forskolin and 2-chloroadenosine, as seen in brain 
tissue [3,8]. Muscarinic stimulation has been 
reported to induce phosphatidylinositol turnover 
in PC 12 cells [ 191, but a muscarinic receptor- 
mediated inhibition of adenylate cyclase proved to 
be the only effect observed with combinations of 
forskolin plus carbamylcholine (not shown). Other 
agents including 6_fluoronorepinephrine, hista- 
mine, serotonin, vasoactive intestinal peptide and 
nerve growth factor did not affect 2-chloro- 
adenosine or forskolin-induced accumulations of 
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cAMP in PC 12 cells (see section 3). The effects of 
these agents on phosphatidylinositol metabolism 
were not ascertained here. However, nerve growth 
factor has been reported to increase incorporation 
of radioactive phosphate or myo-inositol into 
phosphatidy~nositols in PC 12 cells 120,211 and 
sympathetic ganglia 1221. Recently, nerve growth 
factor also was reported to enhance both cholera- 
toxin- and N6-phenylisopropyladenosine-elicited 
accumulation of [3H]cAMP in t3H]adenine-labeled 
PC 12 cells [23]. Further studies will be required to 
establish whether or not there are correlations be- 
tween r~eptor-m~iated phosphatidylinositol 
breakdown and responsiveness of CAMP systems 
in PC 12 cells. 
The site(s) of protein kinase C-catalyzed 
phosphorylation that results in enhanced respon- 
siveness of LAMP-generating systems is unknown, 
but does, based on results with phorbol esters, ap- 
pear relatively general in occurrence. It may repre- 
sent a functional pathway whereby hormonal in- 
puts to phosphatidylinositol and CAMP systems 
can modulate each other. Recently phorbol esters 
were shown to increase adenylate cyclase activity in 
frog erythrocyte lysates [24], representing the first 
instance of this phenomenon in a cell-free system. 
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